Stocks – Tesla, BAT, Newmont Rise in Premarket; Incyte Falls

Investing.com — Stocks in focus in premarket trade on Thursday, 3rd January.

• Tesla (NASDAQ:) stock rose 1.7% after the company reported it shipped a record 112,000 vehicles in the three months through December, 6,000 more than Wall Street forecasts. As such, it delivered roughly 367,500 cars last year, a 50% increase from 2018.
• Incyte (NASDAQ:) stock fell 10.4% after the biopharma company said after the bell on Thursday that its itacitinib drug had failed a late-stage clinical trial. The drug was intended for use in combination with corticosteroids to treat patients whose bodies reject transplanted bone marrow or stem cells.
• • Newmont Goldcorp (NYSE:) stock rose 1.8%, shadowing the rally in the precious metal after a U.S. airstrike killed an Iranian general, triggering a flight to haven assets in markets worldwide.
• Oil producers broadly rose in reaction to the spike in crude prices after the U.S. airstrike. Devon Energy (NYSE:) rose 3.0%, Occidental Petroleum (NYSE:) rose 2.7%, ConocoPhillips (NYSE:) rose 1.6% and Exxon Mobil (NYSE:) rose 1.0%. Chevron (NYSE:) rose 0.7%.
• • Arista Networks (NYSE:) fell 1.4% after it announced the departure of its chief customer officer late on Thursday.
• British American Tobacco (LON:) ADRs rose 2.2% after the company said it will file applications for regulatory approval of all its vaping products by the FDA’s May 12 deadline.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.